Blue electroluminescence has been demonstrated using novel materials 1,3-diphenyl-4-methyl-1H-pyrazolo[3,4-b]quinoline (PAQ4) and 4-phenyl-1,3,5,7-tetramethyl-1,7-dihydrodipyrazolo[3,4-b;4′,3′-e]pyridine (PAP1) for the first time. The peak maxima of their electroluminescent spectra were at 442 nm (ca. 20 nm shift from its photoluminescent maximum) for PAQ4 and 425 nm (within the same spectral range as the photoluminescence) for PAP1.
No takes yet. Share an insight, caveat, or question.
He et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: